Clinical Development of Experimental Therapies for Malignant Glioma
Sultan Qaboos University Medical Journal, 2011 Advances in medical and surgical treatments in the last two to three decades have resulted in quantum leaps in the overall survival of patients with many types of non-central nervous system (CNS) malignant disease, while survival of patients with ...
Nikolai G Rainov, Volkmar Heidecke
doaj
GPA33-Targeted Trimeric Immunotoxin Exhibits Enhanced Antitumor Activity in Human Colorectal Cancer Xenografts. [PDF]
Int J Mol SciRuiz-de-la-Herrán J +4 more
europepmc +1 more source
Dual targeting NG2 and GD3A using Mab-Zap immunotoxin results in reduced glioma cell viability in vitro [PDF]
, 2015 Ashkan, Keyoumars +4 more
core +1 more source
An Innovative Immunotoxin Design Against Allergy Based on the IL-33 Cytokine and the Ribotoxin α-Sarcin. [PDF]
Int J Mol SciNarbona J +5 more
europepmc +1 more source
Birinapant selectively enhances immunotoxin-mediated killing of cancer cells conditional on the IAP protein levels within target cells. [PDF]
FASEB J, 2023 Antignani A +6 more
europepmc +1 more source
Bacterial Protein Toxins as Anticancer Agents: Clinical Potential of <i>Pseudomonas</i> and Anthrax Toxins. [PDF]
Toxins (Basel)Misra R +6 more
europepmc +1 more source
Rapid diagnostic imaging and targeted immunotoxin delivery in aggressive prostate cancer using CEACAM5-specific nanobodies. [PDF]
J NanobiotechnologyXiao Z +15 more
europepmc +1 more source
Evaluation of the Safety of A Novel Anti-HER2 Immunotoxin Containing Modified Fragment of <i>Pseudomonas</i> Exotoxin in BALB/C Mice. [PDF]
Iran J BiotechnolSaadatkhah F +4 more
europepmc +1 more source
Cerebellar Contributions to Spatial Learning and Memory: Effects of Discrete Immunotoxic Lesions. [PDF]
Int J Mol SciLeanza MH +9 more
europepmc +1 more source